Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • canagliflozin

Tag: canagliflozin

You Searched For "Canagliflozin"
Canagliflozin consistently effective for patients of different age groups with diabetic kidney disease

Canagliflozin consistently effective for patients of different age groups with diabetic kidney disease

Dr Kartikeya Kohli21 March 2023 3:45 AM GMT
Australia: Canagliflozin consistently reduced adverse kidney and cardiovascular events in patients with diabetic kidney disease independent of sex or...
Canagliflozin use tied to reduced    proteinuria in  diabetes patients with HF

Canagliflozin use tied to reduced proteinuria in diabetes patients with HF

Dr Kartikeya Kohli7 March 2023 3:30 AM GMT
Japan: Proteinuria regression with canagliflozin treatment in patients with T2DM (type 2 diabetes mellitus) and chronic heart failure (CHF) is...
Is supplementation of SGLT-2 inhibitor beneficial for obese women with PCOS?

Is supplementation of SGLT-2 inhibitor beneficial for obese women with PCOS?

Medha Baranwal28 Sep 2022 4:00 PM GMT
China: Canagliflozin and metformin combination therapy yields similar results as metformin monotherapy for improving weight control,...
Vitamin D Supplementation May Offset Bone Loss Caused by canagliflozin

Vitamin D Supplementation May Offset Bone Loss Caused by canagliflozin

Dr. Kamal Kant Kohli28 Jun 2022 5:30 AM GMT
SGLT2 inhibitors have been shown to slow the progression of diabetes-related kidney disease and is increasingly being considered as a first-line...
All SGLT-2 inhibitors found promising for diabetes management in Indian settings: JAPI

All SGLT-2 inhibitors found promising for diabetes management in Indian settings: JAPI

Medha Baranwal11 Jun 2022 6:00 AM GMT
Maharashtra: SGLT2 Inhibitors could be considered as an add-on to all antidiabetic agents currently used for diabetes management in the Indian...
Canagliflozin does not impact risk of neuropathy events in diabetics, shows data from CREDENCE trial

Canagliflozin does not impact risk of neuropathy events in diabetics, shows data from CREDENCE trial

Medha Baranwal24 Feb 2022 3:30 AM GMT
China: A post-hoc exploratory analysis of the CREDENCE trial revealed that canagliflozin, a SGLT2 inhibitor, did not affect the risk of neuropathy...
Quality of life in heart failure patients may be improved with Canagliflozin category

Quality of life in heart failure patients may be improved with Canagliflozin category

Dr. Nandita Mohan5 Dec 2021 6:00 AM GMT
The CHIEF- HF trial results have shown that treating heart failure (HF) patients with canagliflozin a sodium-glucose cotransporter 2 (SGLT2)...
Canagliflozin reduces hyperkalemia risk in patients with diabetes and CKD: CREDENCE trial

Canagliflozin reduces hyperkalemia risk in patients with diabetes and CKD: CREDENCE trial

MD Editorial Team20 Oct 2021 3:30 AM GMT
Australia: Hyperkalemia is common in people with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), and it is associated with the...
Canagliflozin reduces risk of hyperkalemia in diabetics with CKD: Study

Canagliflozin reduces risk of hyperkalemia in diabetics with CKD: Study

Dr. Shravani Dali28 Aug 2021 3:30 AM GMT
The use of canagliflozin reduces the risk of hyperkalaemia in people with type-2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) without...
Canagliflozin has no substantial effect on serum potassium levels: CANVAS program

Canagliflozin has no substantial effect on serum potassium levels: CANVAS program

Dr. Shravani Dali18 Aug 2021 3:30 AM GMT
Canagliflozin does not have a significant effect on serum potassium levels, suggests a Canagliflozin cardiovascular Assessment Study (CANVAS)...
Canagliflozin use does not significantly reduce MI risk in diabetics: Study

Canagliflozin use does not significantly reduce MI risk in diabetics: Study

Medha Baranwal11 Jun 2021 3:30 AM GMT
Australia: The use of SGLT2 inhibitor canagliflozin does not significantly reduce the risk of myocardial infarction (MI) in the population of CANVAS...
Health Minister discusses side-effects of SGLT-2 inhibitors in the parliament

Health Minister discusses side-effects of SGLT-2 inhibitors in the parliament

Meghna A Singhania8 Feb 2021 10:40 AM GMT
New Delhi: With the rising incidence of diabetes in the country, SGLT-2 inhibitors have emerged as one of the preferred modality of treatment....
Next

Editorial

Journal Club Today

Health News Today

© 2022 All Rights Reserved.
Powered By: Hocalwire
X
X